A previous study has shown that JAK-STAT pathway gene expression is markedly altered during MS and overactivation of the JAK/STAT pathway has pathological significance in autoimmune diseases (Benveniste et al., 2014). This evidence concerns the gene SOAT1 and myeloid sarcoma.